Home/Filings/4/0001209191-22-017058
4//SEC Filing

Schultz Kare 4

Accession 0001209191-22-017058

CIK 0000818686other

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 4:12 PM ET

Size

17.9 KB

Accession

0001209191-22-017058

Insider Transaction Report

Form 4
Period: 2022-03-04
Schultz Kare
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2022-03-04+59,7011,192,197 total
  • Exercise/Conversion

    Ordinary Shares

    2022-03-04+162,5931,354,790 total
  • Exercise/Conversion

    Restricted Share Units

    2022-03-0459,70159,702 total
    Ordinary Shares (59,701 underlying)
  • Award

    Restricted Share Units

    2022-03-04+402,144402,144 total
    Ordinary Shares (402,144 underlying)
  • Exercise/Conversion

    Restricted Share Units

    2022-03-0571,292213,879 total
    Ordinary Shares (71,292 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2022-03-05+71,2921,426,082 total
  • Exercise/Conversion

    Restricted Share Units

    2022-03-04162,5930 total
    Ordinary Shares (162,593 underlying)
Footnotes (6)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F3]Restricted share units were granted on March 4, 2019, with 59,701 having vested on each of March 4, 2021 and March 4, 2022 and 59,702 vesting on March 4, 2023.
  • [F4]Restricted share units were received on February 8, 2022 upon satisfaction of performance criteria and vested on March 4, 2022.
  • [F5]Restricted share units were granted on March 4, 2022, with 100,536 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026.
  • [F6]Restricted share units were granted on March 5, 2021, with 71,292 having vested on March 5, 2022, 71,292 vesting on each of March 5, 2023 and March 5, 2024, and 71,295 vesting on March 5, 2025.

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

Entity typeother

Related Parties

1
  • filerCIK 0001724567

Filing Metadata

Form type
4
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:12 PM ET
Size
17.9 KB